1. Angelakos, E. T., King, M. P., and Carballo, L. 1973. Cardiac adrenergic innervation in hamsters with hereditary myocardiopathy: Chemical and histochemical studies. In: E. Bajusz and G. Rona (eds.), Recent Advances in Studies on Cardiac Structure and Metabolism. Vol. 2: Cardiomyopathies, pp. 519–531. University Park Press, Baltimore.
2. Büchner, F., Onishi, S., and Wada, A. 1978. Cardiomyopathy Associated with Systemic Myopathy, pp. 46–91. Urban & Schwarzenberg, Baltimore, Munich.
3. Ferguson, G. A., 1971. Statistical Analysis in Psychology and Education, 3rd ed., pp. 96–119. McGraw-Hill, New York.
4. Fleckenstein, A. 1971. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: P. Harris and L. Opie (eds.), Calcium and the Heart, pp. 135–188. Academic Press, London.
5. Jasmin, G. 1966. Morphologic effects of vasoactive drugs. Can. J. Physiol. Pharmacol. 44:367–372.